Tracy L. Skaer

2.4k total citations
83 papers, 1.9k citations indexed

About

Tracy L. Skaer is a scholar working on Psychiatry and Mental health, Economics and Econometrics and Pharmacology. According to data from OpenAlex, Tracy L. Skaer has authored 83 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Psychiatry and Mental health, 18 papers in Economics and Econometrics and 16 papers in Pharmacology. Recurrent topics in Tracy L. Skaer's work include Health Systems, Economic Evaluations, Quality of Life (12 papers), Pharmaceutical Practices and Patient Outcomes (11 papers) and Medication Adherence and Compliance (10 papers). Tracy L. Skaer is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (12 papers), Pharmaceutical Practices and Patient Outcomes (11 papers) and Medication Adherence and Compliance (10 papers). Tracy L. Skaer collaborates with scholars based in United States, New Zealand and Canada. Tracy L. Skaer's co-authors include David A. Sclar, Linda M. Robison, Richard S. Galin, Mark P. Okamoto, Ashley Chin, Randy Nakahiro, W. Michael Dickson, C. Eugene Reeder, Mark A. Gill and Alfred Chin and has published in prestigious journals such as The American Journal of Medicine, Drugs and Physiology & Behavior.

In The Last Decade

Tracy L. Skaer

82 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tracy L. Skaer United States	25	724	326	305	277	251	83	1.9k
Dag Isacson Sweden	29	467 0.6×	358 1.1×	148 0.5×	356 1.3×	181 0.7×	64	2.3k
Wim Stalman Netherlands	28	564 0.8×	516 1.6×	253 0.8×	288 1.0×	287 1.1×	56	2.5k
Edward Kim United States	26	1.5k 2.1×	351 1.1×	537 1.8×	161 0.6×	220 0.9×	98	2.8k
Kerstin Bingefors Sweden	21	379 0.5×	249 0.8×	128 0.4×	217 0.8×	119 0.5×	39	1.4k
Robin Eastwood United States	11	1.4k 2.0×	102 0.3×	409 1.3×	123 0.4×	201 0.8×	27	2.0k
Scott Bull United States	14	794 1.1×	291 0.9×	364 1.2×	83 0.3×	247 1.0×	29	1.5k
Elizabeth Lin United States	13	656 0.9×	366 1.1×	590 1.9×	140 0.5×	794 3.2×	21	2.1k
Michela Nosè Italy	25	1.0k 1.4×	175 0.5×	1.0k 3.4×	95 0.3×	417 1.7×	56	2.3k
John S. McIntyre United States	18	671 0.9×	118 0.4×	276 0.9×	257 0.9×	188 0.7×	50	1.9k
Jonathan P. Lacro United States	21	3.3k 4.5×	368 1.1×	1.0k 3.3×	219 0.8×	560 2.2×	36	4.0k

Countries citing papers authored by Tracy L. Skaer

Since Specialization

Citations

This map shows the geographic impact of Tracy L. Skaer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tracy L. Skaer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tracy L. Skaer more than expected).

Fields of papers citing papers by Tracy L. Skaer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tracy L. Skaer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tracy L. Skaer. The network helps show where Tracy L. Skaer may publish in the future.

Co-authorship network of co-authors of Tracy L. Skaer

This figure shows the co-authorship network connecting the top 25 collaborators of Tracy L. Skaer. A scholar is included among the top collaborators of Tracy L. Skaer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tracy L. Skaer. Tracy L. Skaer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Skaer, Tracy L.. (2016). Treatment Recommendations for Fibromyalgia. 2016(4). 3 indexed citations

Skaer, Tracy L.. (2014). Fibromyalgia: Disease Synopsis, Medication Cost Effectiveness and Economic Burden. PharmacoEconomics. 32(5). 457–466. 76 indexed citations

Sclar, David A., et al.. (2012). Concomitant Use of Triptan, and SSRI or SNRI After the US Food and Drug Administration Alert on Serotonin Syndrome. Headache The Journal of Head and Face Pain. 52(2). 198–203. 18 indexed citations

Willson, Megan N., Joshua J. Neumiller, David A. Sclar, Linda M. Robison, & Tracy L. Skaer. (2010). Ethnicity/Race, Use of Pharmacotherapy, Scope of Physician-Ordered Cholesterol Screening, and Provision of Diet/Nutrition or Exercise Counseling during US Office-Based Visits by Patients with Hyperlipidemia. American Journal of Cardiovascular Drugs. 10(2). 105–108. 14 indexed citations

Sclar, David A., et al.. (2005). Economic and Epidemiological Modelling of Full-Length Antihaemophilic Factor (Recombinant), Plasma/Albumin-Free Method, in Previously Treated Patients with Haemophilia A. Drugs in R&D. 6(3). 149–156. 3 indexed citations

Robison, Linda M., Tracy L. Skaer, & David A. Sclar. (2004). Is Attention-Deficit Hyperactivity Disorder (ADHD) Diagnosed in Adults?. International Journal of Pharmaceutical Medicine. 18(6). 337–341. 9 indexed citations

Skaer, Tracy L.. (2004). Practice Guidelines for Transdermal Opioids in Malignant Pain. Drugs. 64(23). 2629–2638. 46 indexed citations

Skaer, Tracy L., David A. Sclar, Linda M. Robison, & Richard S. Galin. (2001). Trends in the Rate of Self-Report and Diagnosis of Erectile Dysfunction in the United States 1990-1998. Disease Management & Health Outcomes. 9(1). 33–41. 5 indexed citations

Skaer, Tracy L., David A. Sclar, Linda M. Robison, & Richard S. Galin. (2000). The Need for an Iterative Process for Assessing Economic Outcomes Associated with SSRIs. PharmacoEconomics. 18(3). 205–214. 6 indexed citations

10.

Sclar, David A., et al.. (1999). Sulfonylurea Pharmacotherapy Regimen Adherence in a Medicaid Population: Influence of Age, Gender, and Race. The Diabetes Educator. 25(4). 531–538. 38 indexed citations

11.

Skaer, Tracy L.. (1998). Cancer Pain Management. American Journal of Pharmaceutical Education. 62(2). 182–189.

12.

Sclar, David A., et al.. (1998). Economic outcomes with antidepressant pharmacotherapy: a retrospective intent-to-treat analysis.. PubMed. 59 Suppl 2. 13–7. 30 indexed citations

13.

Sclar, David A., et al.. (1998). Antidepressant Prescribing Patterns. Clinical Drug Investigation. 16(2). 135–140. 20 indexed citations

14.

Skaer, Tracy L., et al.. (1993). Effect of value-added utilities on prescription refill compliance and health care expenditures for hypertension.. PubMed. 7(5). 515–8. 46 indexed citations

15.

Skaer, Tracy L., et al.. (1993). Effect of pharmaceutical formulation for diltiazem on health care expenditures for hypertension.. PubMed. 15(5). 905–11. 13 indexed citations

16.

Skaer, Tracy L., et al.. (1993). Effect of pharmaceutical formulation for antihypertensive therapy on health service utilization.. PubMed. 15(4). 715–25; discussion 714. 16 indexed citations

17.

Skaer, Tracy L., et al.. (1993). Effect of academic detailing on the utilization of intravenous antimicrobial therapy. Current Therapeutic Research. 53(4). 349–355. 4 indexed citations

18.

Skaer, Tracy L., et al.. (1993). Effect of value-added utilities in promoting prescription refill compliance among patients with hypertension. Current Therapeutic Research. 53(3). 251–255. 8 indexed citations

19.

Sclar, David A., Tracy L. Skaer, Alfred Chin, Mark P. Okamoto, & Mark A. Gill. (1991). Utility of a transdermal delivery system for antihypertensive therapy. Part 2. The American Journal of Medicine. 91(1). S57–S60. 13 indexed citations

20.

Sclar, David A., Tracy L. Skaer, Alfred Chin, Mark P. Okamoto, & Mark A. Gill. (1991). Utility of a transdermal delivery system for antihypertensive therapy. Part 1. The American Journal of Medicine. 91(1). S50–S56. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact